Bispecific antibody-mediated cytotoxicity by CD4+ and CD8(+)-activated T cells generated from leukemia patients after allogeneic bone marrow transplantation.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Bone Marrow Transplantation

• Publication date

  1995-02-01

• Fields of study

  Medicine

• Identifiers
  PMID 7773208
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Specific targeting of in vitro‐activated human antitumour effector cells using anti‐CD3 × anti‐c‐erbB‐2 bispecific antibody

  1993cited by this paper
• Large-scale culture system of human CD4+ helper/killer T cells for the application to adoptive tumour immunotherapy.

  1992cited by this paper
• Interleukin-2 (IL-2) and IL-2-activated bone marrow in transplantation: evaluation from a clinical perspective.

  1992cited by this paper
• Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy.

  1992cited by this paper
• Intensive immunotherapy with recombinant IL2 after autologous bone marrow transplantation is associated with a high incidence of bacterial infections.

  1992cited by this paper
• Increased lysis of patient CD10-positive leukemic cells by T cells coated with anti-CD3 Fab' antibody cross-linked to anti-CD10 Fab' antibody.

  1991cited by this paper
• Autologous bone marrow transplantation in high-risk remission T-lineage acute lymphoblastic leukemia using immunotoxins plus 4-hydroperoxycyclophosphamide for marrow purging.

  1990cited by this paper
• Preliminary trial of specific targeting therapy against malignant glioma.

  1990cited by this paper
• Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survival.

  1989cited by this paper
• Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report.

  1988cited by this paper
• High-dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myeloma.

  1987cited by this paper
• Human T cells targeted with anti-T3 cross-linked to antitumor antibody prevent tumor growth in nude mice.

  1987cited by this paper
• Induction of cytotoxicity in human peripheral blood mononuclear cells by monoclonal antibody OKT3.

  1987cited by this paper
• Serological analysis of cell surface antigens of null cell acute lymphocytic leukemia by mouse monoclonal antibodies.

  1982cited by this paper
• Continuous culture of T cells cytotoxic for autologous human leukaemia cells

  1979cited by this paper

• Bispecific antibodies for treatment of cancer in experimental animal models and man.

  1998cites this paper
• Reconstitution of immune systems in RAG2-/- mice by transfer with interleukin-12-induced splenic hematopoietic progenitor cells.

  1998cites this paper
• Activation of T cell cytotoxicity against autologous common acute lymphoblastic leukemia (cALL) blasts by CD3xCD19 bispecific antibody.

  1996cites this paper